☆ 4.3 Article

Identification of Immune-Related lncRNAs for Predicting Prognosis and Immune Landscape Characteristics of Uveal Melanoma

JOURNAL OF ONCOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Tebentafusp for the treatment of metastatic uveal melanoma

Timo E. Schank et al.

Summary: Uveal melanoma is a rare disease but the most common eye tumor among adults. It often metastasizes to the liver. Standard treatments have shown poor outcomes, but the new treatment tebentafusp has shown promising results in recent clinical trials. This review discusses the latest study results and the immunological strategy of tebentafusp for treating uveal melanoma.

FUTURE ONCOLOGY (2022)

添加到收藏夹

Article Oncology

lncRNA ELFN1-AS1 predicts poor prognosis and promotes tumor progression of non-small cell lung cancer by sponging miR-497

Bin Yang et al.

Summary: The study found that ELFN1-AS1 is upregulated in non-small cell lung cancer (NSCLC) and is closely associated with disease staging, lymph node metastasis, and overall patient survival. Silencing of ELFN1-AS1 inhibits cellular processes and EMT in NSCLC. ELFN1-AS1 may function through the miR-497/CCNE1 axis.

CANCER BIOMARKERS (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Hypoxia-Induced Upregulation of lncRNA ELFN1-AS1 Promotes Colon Cancer Growth and Metastasis Through Targeting TRIM14 via Sponging miR-191-5p

Xu Jing et al.

Summary: The study demonstrates that ELFN1-AS1 is upregulated by hypoxia in colon cancer cells and promotes proliferation and invasion while inhibiting apoptosis by sponging miR-191-5p to upregulate TRIM14. This finding enriches our understanding of colon cancer progression and provides potential targets for clinical treatment.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Article Immunology

Computed Tomography Imaging-Based Radiogenomics Analysis Reveals Hypoxia Patterns and Immunological Characteristics in Ovarian Cancer

Songwei Feng et al.

Summary: This study aims to develop a non-invasive radiogenomics approach for identifying a hypoxia pattern in ovarian cancer and predicting patient prognostication. Hypoxia-related genes and subtypes were identified based on RNA-seq analysis of OC cell lines. Various bioinformatics algorithms were used to explore immune microenvironment, prognosis, pathway alteration, and drug sensitivity. A radiogenomics model was constructed for predicting patient risk status. The study demonstrates the potential of computed tomography-based radiogenomics biomarkers in predicting hypoxia pattern, prognosis, therapeutic effect, and immune microenvironment in OC patients.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Genetics & Heredity

Identification of Immunological Characteristics and Immune Subtypes Based on Single-Sample Gene Set Enrichment Analysis Algorithm in Lower-Grade Glioma

Yunyang Zhu et al.

Summary: This study used bioinformatics methods to identify four immunotypes of lower-grade glioma (LGG) and found correlations between these immunotypes and clinical and immunogenomic factors. The study also revealed that LGGs in one immunotype were sensitive to certain drugs and immune checkpoint inhibitors, and were affected by specific pathways.

FRONTIERS IN GENETICS (2022)

添加到收藏夹

Article Immunology

Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer

Jirong Wang et al.

Summary: Recent study identified seven immune-related lncRNAs with prognostic value for bladder cancer (BC) patients through TCGA database, and constructed a signature for predicting prognosis. The signature was confirmed to be an independent prognostic factor and showed different immune statuses between low- and high-risk groups. This study suggests that the identified lncRNA signature can serve as a prognostic marker for BC.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

添加到收藏夹

Review Oncology

Genetic Landscape and Emerging Therapies in Uveal Melanoma

Rino S. Seedor et al.

Summary: Uveal melanoma presents unique genetic landscape, potentially offering insights for prognosis and treatment. Current knowledge is primarily based on primary cases, highlighting the need for a better understanding of the mutational landscape in metastatic cases. Ongoing clinical trials targeting specific mutations have shown promise in this field.

CANCERS (2021)

添加到收藏夹

Article Reproductive Biology

Identification of potential markers for differentiating epithelial ovarian cancer from ovarian low malignant potential tumors through integrated bioinformatics analysis

Wende Hao et al.

Summary: By conducting an integrated bioinformatic analysis, potential biomarkers, risk factors, and drugs for EOC were identified, providing new insights for the diagnosis, condition appraisal, prevention, and treatment of EOC in the future.

JOURNAL OF OVARIAN RESEARCH (2021)

添加到收藏夹

Article Genetics & Heredity

Identification and Functional Prediction of Long Non-Coding RNAs in Dilated Cardiomyopathy by Bioinformatics Analysis

Yu-Xiao Chen et al.

Summary: The study identified eight candidate lncRNAs associated with DCM disease and suggested their potential involvement in DCM through ceRNA crosstalk. These findings contribute to the discovery of therapeutic targets and enhance the understanding of DCM pathogenesis.

FRONTIERS IN GENETICS (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Identification of Six Autophagy-Related-lncRNA Prognostic Biomarkers in Uveal Melanoma

Yao Chen et al.

Summary: This study identified and constructed a predictive model for autophagy-related lncRNAs in uveal melanoma patients using samples from the TCGA database. The model, consisting of six lncRNAs, was found to be a significant independent prognostic factor, concentrated in biological pathways related to cytoplasmic component recycling, energy metabolism, and apoptosis. These lncRNAs have potential as molecular biomarkers and treatment targets for uveal melanoma patients.

DISEASE MARKERS (2021)

添加到收藏夹

Article Ophthalmology

The Genetics of Uveal Melanoma: Overview and Clinical Relevance

Aline Isabel Riechardt et al.

Summary: Uveal melanoma differs fundamentally from non-uveal melanoma and is an independent genetic subtype with low mutational burden. Significantly mutated genes, including some associated with a higher risk of metastasis, have been identified. Further genetic counseling and screening of family members should be offered in relevant cases.

KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE (2021)

添加到收藏夹

Article Ophthalmology

Identification and validation of tumor microenvironment-related lncRNA prognostic signature for uveal melanoma

Chen-Lu Liao et al.

Summary: Bioinformatics analysis identified potential prognostic markers and small molecule drugs for uveal melanoma (UM) related to tumor microenvironment (TME)-associated long non-coding RNA (lncRNA). The study expands our understanding of the role of TME-related lncRNAs in UM genesis and provides reliable biomarkers for UM prognosis.

INTERNATIONAL JOURNAL OF OPHTHALMOLOGY (2021)

添加到收藏夹

Article Medicine, Research & Experimental

m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD

Feng Xu et al.

Summary: This study established a risk model for predicting the prognosis and immunotherapeutic response of LUAD patients based on m(6)A-related lncRNAs, which can effectively distinguish patients and fit clinical predictions. The research also identified candidate compounds targeting LUAD subtypes.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

添加到收藏夹

Review Oncology

The Role of LncRNAs in Uveal Melanoma

Paula Milan-Rois et al.

Summary: Uveal melanoma is a rare and deadly cancer that requires novel treatment and diagnostic approaches. Long non-coding RNAs (lncRNAs) are crucial in cancer and other diseases, offering potential as therapeutic targets and diagnostic markers. Understanding lncRNAs related to uveal melanoma could inspire the development of new treatments and diagnostics, with their interaction with other non-coding RNAs playing a significant role in cancer development.

CANCERS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma

Ji Yin et al.

Summary: This study developed an immune-related lncRNA model for risk assessment and prognosis prediction in HNSCC patients, which effectively differentiated between low- and high-risk groups in terms of survival, clinico-pathological characteristics, tumor immune infiltrating status, chemotherapeutics sensitivity, and immunosuppressive molecules. A 13-irlncRNA-pair signature was built and showed high sensitivity and specificity for survival prediction, with the high-risk group exhibiting significantly poorer survival rates and negative relationships with immune infiltrations. Moreover, differences in chemotherapeutics sensitivity and molecular marker expression levels were also observed between high- and low-risk groups.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

添加到收藏夹

Review Ophthalmology

Uveal melanoma: Towards a molecular understanding

Kyra N. Smit et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2020)

添加到收藏夹

Review Oncology

Update on uveal melanoma: Translational research from biology to clinical practice (Review)

Miguel A. Ortega et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma

Weifeng Hong et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer

Youkun Jie et al.

BIOENGINEERED (2020)

添加到收藏夹

Review Oncology

Uveal melanoma: physiopathology and new in situ-specific therapies

E. B. Souto et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)

添加到收藏夹

Review Oncology

Immunotherapies for the Treatment of Uveal Melanoma-History and Future

Timo E. Schank et al.

CANCERS (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Role of Non-coding RNAs in Oncology

Frank J. Slack et al.

CELL (2019)

添加到收藏夹

Article Oncology

Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma

Kalijn Fredrike Bol et al.

CANCERS (2019)

添加到收藏夹

Editorial Material Ophthalmology

Continued Poor Survival in Metastatic Uveal Melanoma Implications for Molecular Prognostication, Surveillance Imaging, Adjuvant Therapy, and Clinical Trials

Douglas B. Johnson et al.

JAMA OPHTHALMOLOGY (2018)

添加到收藏夹

Review Oncology

Treatment of uveal melanoma: where are we now?

Jessica Yang et al.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)

添加到收藏夹

Article Oncology

Clinical Outcomes in Metastatic Uveal Melanoma Treated With PD-1 and PD-L1 Antibodies

Alain P. Algazi et al.

CANCER (2016)

添加到收藏夹

Review Oncology

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

Suzanne L. Topalian et al.

NATURE REVIEWS CANCER (2016)

添加到收藏夹

Review Immunology

Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism?

Jerry Y. Niederkorn

FRONTIERS IN IMMUNOLOGY (2012)

添加到收藏夹

Article Ophthalmology

Uveal Melanoma: Trends in Incidence, Treatment, and Survival

Arun D. Singh et al.

OPHTHALMOLOGY (2011)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.